Page 1319 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

4 References

are critical for cleavage of von Willebrand factor. Blood. 110. Noris M, Brioschi S, Caprioli J, et al. Familial haemolytic urae-
2010;115(11):2300-2310. mic syndrome and an MCP mutation. Lancet. 2003;362(9395):
93. Xiao J, Jin SY, Xue J, Sorvillo N, Voorberg J, Zheng XL. Essential 1542-1547.
domains of a disintegrin and metalloprotease with thrombos- 111. Richards A, Kemp EJ, Liszewski MK, et al. Mutations in human
pondin type 1 repeats-13 metalloprotease required for modu- complement regulator, membrane cofactor protein (CD46),
lation of arterial thrombosis. Arterioscler Thromb Vasc Biol. predispose to development of familial hemolytic uremic syn-
2011;31(10):2261-2269. drome. Proc Natl Acad Sci U S A. 2003;100(22):12966-12971.
94. Zheng XL, Nishio K, Majerus EM, Sadler JE. Cleavage of von 112. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J, et al.
Willebrand factor requires the spacer domain of the metallopro- Complement factor I: a susceptibility gene for atypical haemo-
tease ADAMTS13. J Biol Chem. 2003;278(32):30136-30141. lytic uraemic syndrome. J Med Genet. 2004;41(6):e84.
95. Chauhan AK, Motto DG, Lamb CB, et al. Systemic antithrom- 113. Goicoechea de JE, Harris CL, Esparza-Gordillo J, et al. Gain-of-
botic effects of ADAMTS13. J Exp Med. 2006;203(3):767-776. function mutations in complement factor B are associated with
96. Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A.
Wagner DD. ADAMTS13: a new link between thrombosis and 2007;104(1):240-245.
inflammation. J Exp Med. 2008;205(9):2065-2074. 114. Fremeaux-Bacchi V, Miller EC, Liszewski MK, et al. Mutations
97. Tsai HM, Rice L, Sarode R, Chow TW, Moake JL. Antibody in complement C3 predispose to development of atypical hemo-
inhibitors to von Willebrand factor metalloproteinase and lytic uremic syndrome. Blood. 2008;112(13):4948-4952.
increased binding of von Willebrand factor to platelets in 115. Roumenina LT, Jablonski M, Hue C, et al. Hyperfunctional C3
ticlopidine-associated thrombotic thrombocytopenic purpura. convertase leads to complement deposition on endothelial cells
Ann Intern Med. 2000;132(10):794-799. and contributes to atypical hemolytic uremic syndrome. Blood.
98. Moatti-Cohen M, Garrec C, Wolf M, et al. Unexpected frequency 2009;114(13):2837-2845.
of Upshaw-Schulman syndrome in pregnancy-onset thrombotic 116. Blanc C, Roumenina LT, Ashraf Y, et al. Overall neutralization
thrombocytopenic purpura. Blood. 2012;119(24):5888-5897. of complement factor h by autoantibodies in the acute phase of
99. Veyradier A, Stepanian A, Coppo P. ADAMTS13, thrombotic the autoimmune form of atypical hemolytic uremic syndrome.
thrombocytopenic purpura and pregnancy. Hereditary Genetics. J Immunol. 2012;189(7):3528-3537.
2012;S1:002-007. 117. Kavanagh D, Pappworth IY, Anderson H, et al. Factor I auto-
100. May HV Jr, Harbert GM Jr, Thornton WN Jr. Thrombotic antibodies in patients with atypical hemolytic uremic syn-
thrombocytopenic purpura associated with pregnancy. Am J drome: disease-associated or an epiphenomenon? Clin J Am Soc
Obstet Gynecol. 1976;126(4):452-458. Nephrol. 2012;7(3):417-426.
101. Atlas M, Barkai G, Menczer J, Houlu N, Lieberman P. 118. Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-Factor H
Thrombotic thrombocytopenic purpura in pregnancy. Br J autoantibodies associated with atypical hemolytic uremic syn-
Obstet Gynaecol. 1982;89(6):476-479. drome. J Am Soc Nephrol. 2005;16(2):555-563.
102. Egerman RS, Witlin AG, Friedman SA, Sibai BM. Thrombotic 119. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syn-
thrombocytopenic purpura and hemolytic uremic syndrome in drome during an outbreak of Escherichia coli O157:H7 infec-
pregnancy: review of 11 cases. Am J Obstet Gynecol. 1996;175 tions in institutions for mentally retarded persons: clinical and
(4, pt 1):950-956. epidemiologic observations. J Pediatr. 1990;116(4):544-551.
103. Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM. 120. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr
Mild to moderate reduction of a von Willebrand factor cleaving PI. Predictors of hemolytic uremic syndrome in children dur-
protease (ADAMTS13) in pregnant women with HELLP micro- ing a large outbreak of Escherichia coli O157:H7 infections.
angiopathic syndrome. Haematologica. 2003;88(9):1029-1034. Pediatrics. 1997;100(1):E12.
104. Griffin PM, Tauxe RV. The epidemiology of infections caused 121. Griener TP, Mulvey GL, Marcato P, Armstrong GD. Differential
by Escherichia coli O157:H7, other enterohemorrhagic E. coli, binding of Shiga toxin 2 to human and murine neutrophils.
and the associated hemolytic uremic syndrome. Epidemiol Rev. J Med Microbiol. 2007;56(pt 11):1423-1430.
1991;13:60-98. 122. Psotka MA, Obata F, Kolling GL, et al. Shiga toxin 2 targets
105. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, the murine renal collecting duct epithelium. Infect Immun.
Griffin PM. Escherichia coli O157:H7 diarrhea in the United 2009;77(3):959-969.
States: clinical and epidemiologic features. Ann Intern Med. 123. Ergonul Z, Hughes AK, Kohan DE. Induction of apoptosis of
1997;126(7):505-513. human brain microvascular endothelial cells by shiga toxin 1.
106. Rougier N, Kazatchkine MD, Rougier JP, et al. Human comple- J Infect Dis. 2003;187(1):154-158.
ment factor H deficiency associated with hemolytic uremic 124. Stricklett PK, Hughes AK, Ergonul Z, Kohan DE. Molecular
syndrome. J Am Soc Nephrol. 1998;9(12):2318-2326. basis for up-regulation by inflammatory cytokines of Shiga
107. Ying L, Katz Y, Schlesinger M, et al. Complement factor H gene toxin 1 cytotoxicity and globotriaosylceramide expression.
mutation associated with autosomal recessive atypical hemo- J Infect Dis. 2002;186(7):976-982.
lytic uremic syndrome. Am J Hum Genet. 1999;65(6):1538-1546. 125. Morigi M, Galbusera M, Binda E, et al. Verotoxin-1-induced
108. Taylor CM. Complement factor H and the haemolytic uraemic up-regulation of adhesive molecules renders microvascular
syndrome. Lancet. 2001;358(9289):1200-1202. endothelial cells thrombogenic at high shear stress. Blood.
109. Zipfel PF, Skerka C, Caprioli J, et al. Complement factor 2001;98(6):1828-1835.
H and hemolytic uremic syndrome. Int Immunopharmacol. 126. Huang J, Motto DG, Bundle DR, Sadler JE. Shiga toxin B sub-
2001;1(3):461-468. units induce VWF secretion by human endothelial cells and

Section07-O-ref.indd 4 1/21/2015 11:26:49 AM